SCHEMBL30816278

CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 7)

	gene	UniProt	supporting neighbours	confidence
▸	NPY2R	P49146	8/20	0.65

▸	NPY4R	P50391	8/20	0.65

▸	NPY5R	Q15761	8/20	0.65

▸	NPY1R	P25929	6/20	0.65

▸	KISS1R	Q969F8	3/20	0.57

▸	GLP1R	P43220	3/20	0.57

▸	OPRD1	P41143	2/20	0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30906385	0.92	NPY2R (0.71)	NPY2RNPY4RNPY5RNPY1RGLP1R
SCHEMBL30429115	0.91	NPY1R (0.64)	NPY2RNPY4RNPY5RNPY1RGLP1R
SCHEMBL30906461	0.90	NPY1R (0.68)	NPY2RNPY4RNPY5RNPY1RGLP1R
SCHEMBL29811065	0.89	NPY2R (0.71)	NPY2RNPY4RNPY5RNPY1RGLP1R
SCHEMBL29679514	0.88	NPY1R (0.68)	NPY2RNPY4RNPY5RNPY1RGLP1R
SCHEMBL30729468	0.88	NPY1R (0.61)	NPY2RNPY4RNPY5RNPY1RKISS1R
SCHEMBL30648474	0.87	NPY1R (0.66)	NPY2RNPY4RNPY5RNPY1RGLP1R
SCHEMBL30906422	0.87	NPY1R (0.68)	NPY2RNPY4RNPY5RNPY1RGLP1R
SCHEMBL30495771	0.87	NPY1R (0.65)	NPY2RNPY4RNPY5RNPY1RGLP1R
SCHEMBL29679866	0.87	NPY1R (0.72)	NPY2RNPY4RNPY5RNPY1RGLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240059758-A1	THERAPEUTIC ANTIBODIES WITH NEUTRALIZING ACTIVITY AGAINST SARS-COV-2 GLYCOPROTEIN S	CORAT THERAPEUTICS GMBH (DE)	2024-02-22	—	—	US	claimed